Per consultare direttamente la bibliografia:
– Brain Sci. 2020 Jun 9;10(6):E360. Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
– Cells. 2020 Jun 20;9(6):E1507. Role of 2-Arachidonoyl-Glycerol and CB1 Receptors in Orexin-A-Mediated Prevention of Oxygen-Glucose Deprivation-Induced Neuronal Injury
– Br J Pharmacol. 2020 Jun;177(12):2712-2725. An Evaluation of the Anti-Hyperalgesic Effects of Cannabidiolic Acid-Methyl Ester in a Preclinical Model of Peripheral Neuropathic Pain
– Br J Clin Pharmacol. 2020 Jun 1. A Pilot Randomised Placebo-Controlled Trial of Cannabidiol to Reduce Severe Behavioural Problems in Children and Adolescents With Intellectual Disability
– Complement Ther Med. 2020 Jun;51:102407. Does Religiosity Matter? University Student Attitudes and Beliefs Toward Medical Cannabis
© 2023 Cannabiscienza SRL | P.IVA: 02921460305
Segreteria: info@cannabiscienza.it
Sede operativa: Via Watt,
13 – 20143 Milano (MI)
Sede legale: Via di Prampero 1,
33035, Martignacco (UD)
Provider nazionale ECM FAD n° 6404
© Copyright 2023 All rights reserved Cannabiscienza